drugset / Trial / NCT02818309
Lesogaberan in Chinese Patients With Refractory Reflux Symptoms
Phase 2
Unknown
72 enrolled
National Taiwan University Hospital
Ministry of Science and Technology, Taiwan · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Lesogaberan may be used in Chinese GERD patients with partial response to PPI.
Timeline
- Start
- 2015-01
- Primary completion
- 2017-11
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | lesogaberan | Small molecule | 120 mg | — |